Keywords: j/s-p, simponi, cleared, canada, health, approved, johnson
J&J/S-P's Simponi cleared in Canada
Article | 14 April 2009
Health Canada has approved Johnson & Johnson and Schering-Plough's Simponi (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderately-to-severely ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
